Literature DB >> 31062990

Removing the mask on hypertension (REMAH) study: Design; quality of blood pressure phenotypes and characteristics of the first 490 participants.

Peter C Nwakile1, Babangida S Chori2, Benjamin Danladi2, Abdullahi Umar3, Innocent C Okoye4, Maxwell Nwegbu5, Kefas Zawaya6, Ime Essien7, Kabiru Sada3, John Ogedengbe8, Akinyemi Aje9, Godsent Isiguzo10, Augustine N Odili2.   

Abstract

Purpose: Previous studies that evaluated the prevalence of hypertension in Nigeria were either clinic based, non-standardized or did not include out-of-clinic blood pressure (BP) measurement. Materials and
Methods: We selected a rural and an urban community in one state in each of the 6 geopolitical zones of Nigeria. Five consecutive BP of adults older than 18 years were measured in the clinic following which, each participant was provided with a home BP device to obtain duplicate morning and evening BP for 3 days. Result: Out of 556 invited from Anambra State, South-East Nigeria, 490 (88%) consented. Overall, more women participated in both rural (115 vs 61, p < .0001) and urban (213 vs 101; p < .0001) sites. About 35.9% of participants had their home BP monitored. Of the 4890 clinic BP readings, 29.8%, 16.3%, 16.6%, 16.4% and 20.8% ended in 0,2,4,6 and 8 digits respectively. Only 0.8% ended in odd numbers. Of the identical BP readings,5 (0.20%), 6 (0.25%), 56 (2.30%) and 316 (12.9%) SBP and 8 (0.33%), 17 (0.70%), 93 (3.80%), 319 (13.1%) DBP had no difference in five, four, three and two values of the five consecutive readings.
Conclusion: REMAH is feasible and the quality of BP will ensure that the final results are robust.

Entities:  

Keywords:  Masked hypertension; Out-of-clinic BP; Quality control; White-coat hypertension

Mesh:

Year:  2019        PMID: 31062990     DOI: 10.1080/08037051.2019.1612706

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  4 in total

1.  Prevalence, patterns and predictors of dyslipidaemia in Nigeria: a report from the REMAH study.

Authors:  Babangida Chori; Benjamin Danladi; Peter Nwakile; Innocent Okoye; Umar Abdullahi; Kefas Zawaya; Ime Essien; Kabiru Sada; Maxwell Nwegbu; John Ogedengbe; Akinyemi Aje; Godsent Isiguzo; Augustine Odili
Journal:  Cardiovasc J Afr       Date:  2021-11-15       Impact factor: 0.802

2.  Socio-demographic and lifestyle factors associated with hypertension in Nigeria: results from a country-wide survey.

Authors:  Azuka S Adeke; Babangida S Chori; Dinesh Neupane; James E Sharman; Augustine N Odili
Journal:  J Hum Hypertens       Date:  2022-03-24       Impact factor: 3.012

3.  Hyperhomocysteinemia and its relations to conventional risk factors for cardiovascular diseases in adult Nigerians: the REMAH study.

Authors:  Babangida S Chori; Benjamin Danladi; Bassey A Inyang; Michael P Okoh; Maxwell M Nwegbu; Adewale L Alli; Augustine N Odili
Journal:  BMC Cardiovasc Disord       Date:  2021-02-18       Impact factor: 2.298

4.  Prevalence, Awareness, Treatment and Control of Hypertension in Nigeria: Data from a Nationwide Survey 2017.

Authors:  Augustine N Odili; Babangida S Chori; Benjamin Danladi; Peter C Nwakile; Innocent C Okoye; Umar Abdullahi; Maxwell N Nwegbu; Kefas Zawaya; Ime Essien; Kabiru Sada; John O Ogedengbe; Akinyemi Aje; Godsent C Isiguzo
Journal:  Glob Heart       Date:  2020-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.